ATE132494T1 - Substituierte 3-piperazinylalkyl 2,3-dihydro-4h- 1,3-benzoxazin-4-one, deren herstellung und verwendung in heilkunde - Google Patents

Substituierte 3-piperazinylalkyl 2,3-dihydro-4h- 1,3-benzoxazin-4-one, deren herstellung und verwendung in heilkunde

Info

Publication number
ATE132494T1
ATE132494T1 AT92402218T AT92402218T ATE132494T1 AT E132494 T1 ATE132494 T1 AT E132494T1 AT 92402218 T AT92402218 T AT 92402218T AT 92402218 T AT92402218 T AT 92402218T AT E132494 T1 ATE132494 T1 AT E132494T1
Authority
AT
Austria
Prior art keywords
piperazinylalkyl
dihydro
substituted
benzoxazine
medicine
Prior art date
Application number
AT92402218T
Other languages
English (en)
Inventor
Jean-Pierre Rieu
Dennis Bigg
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE132494T1 publication Critical patent/ATE132494T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT92402218T 1991-08-05 1992-08-03 Substituierte 3-piperazinylalkyl 2,3-dihydro-4h- 1,3-benzoxazin-4-one, deren herstellung und verwendung in heilkunde ATE132494T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9109946A FR2680172B1 (fr) 1991-08-05 1991-08-05 Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
ATE132494T1 true ATE132494T1 (de) 1996-01-15

Family

ID=9415938

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92402218T ATE132494T1 (de) 1991-08-05 1992-08-03 Substituierte 3-piperazinylalkyl 2,3-dihydro-4h- 1,3-benzoxazin-4-one, deren herstellung und verwendung in heilkunde

Country Status (9)

Country Link
US (1) US5308844A (de)
EP (1) EP0527081B1 (de)
JP (1) JPH05194441A (de)
AT (1) ATE132494T1 (de)
DE (1) DE69207301T2 (de)
DK (1) DK0527081T3 (de)
ES (1) ES2083708T3 (de)
FR (1) FR2680172B1 (de)
GR (1) GR3019274T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE152102T1 (de) * 1991-05-10 1997-05-15 Takeda Chemical Industries Ltd Pyridinderivate, deren herstellung und anwendung
IT1266992B1 (it) * 1993-04-16 1997-01-24 Alfa Wassermann Spa Composti eterociclici, a struttura correlabile alle banzammidi, attivi nelle patologie gastro-intestinali, ad attivita' procinetica ed
FR2707294B1 (fr) * 1993-07-06 1995-09-29 Pf Medicament Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
IT1264812B1 (it) * 1993-07-28 1996-10-10 Italfarmaco Spa Derivati benzossazinonici e benzotiazinonici terapeuticamente attivi
US5597922A (en) * 1994-07-29 1997-01-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Glycine receptor antagonist pharmacophore
FR2727682A1 (fr) * 1994-12-02 1996-06-07 Pf Medicament Nouveaux derives de 3,5-dioxo-(2h,4h)-1,2,4-triazines, leur preparation et leur application a titre de medicament
EP0875512A3 (de) * 1997-04-16 1999-04-07 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. (Faes) Naphthylpiperazin-Derivate mit antipsychotischer Wirkung
JP2005231995A (ja) * 1999-12-22 2005-09-02 Meiji Seika Kaisha Ltd オピオイドδ受容体アゴニスト／アンタゴニストとして有用なスピロ化合物
US20030165987A1 (en) * 2000-02-18 2003-09-04 Aspira Biosystems, Inc. Compositions and methods for surface imprinting
DE10031391A1 (de) * 2000-07-03 2002-02-07 Knoll Ag Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
ES2462240T3 (es) * 2006-02-28 2014-05-22 Dart Neuroscience (Cayman) Ltd Piperazinas terapéuticas como inhibidores de PDE4
EP2299814A4 (de) * 2008-05-27 2011-06-15 Reviva Pharmaceuticals Inc Zusammensetzungen, synthese und verfahren zur verwendung von antipsychotika auf piperazinbasis
KR101705727B1 (ko) 2009-02-26 2017-02-10 레비바 파마슈티칼스, 아이엔씨. 아릴피페라진 유도체의 조성물, 합성, 및 사용 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
EP0233728A1 (de) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazin-Derivate, ihre Herstellung und Verwendung
FR2636065B1 (fr) * 1988-09-08 1993-05-07 Fabre Sa Pierre Nouveaux derives de dihydro-2,3 arylacoylaminoalcoyl-3 4h-benzoxazine-1,3 ones-4, leur preparation et leur application en tant que medicaments utiles en therapeutique

Also Published As

Publication number Publication date
US5308844A (en) 1994-05-03
DE69207301D1 (de) 1996-02-15
EP0527081A1 (de) 1993-02-10
JPH05194441A (ja) 1993-08-03
DK0527081T3 (da) 1996-04-09
ES2083708T3 (es) 1996-04-16
EP0527081B1 (de) 1996-01-03
FR2680172B1 (fr) 1993-11-19
DE69207301T2 (de) 1996-08-29
GR3019274T3 (en) 1996-06-30
FR2680172A1 (fr) 1993-02-12

Similar Documents

Publication Publication Date Title
DE69713152D1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
DE69713148D1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
SE8700499D0 (sv) Novel pharmacologically active compounds
DE3883016D1 (de) Komplexe verbindungen aus bioflavonoiden mit phospholipiden, ihre herstellung und verwendung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
SE9604786D0 (sv) New compounds
ATE132494T1 (de) Substituierte 3-piperazinylalkyl 2,3-dihydro-4h- 1,3-benzoxazin-4-one, deren herstellung und verwendung in heilkunde
ATE290015T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen
NO872686D0 (no) Nye farmakologiske forbindelser.
ES2123039T3 (es) Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
DE69216293D1 (de) 1,4-Disubstituierte Piperidinderivate, ihre Herstellung und therapeutische Verwendung
PT734383E (pt) Derivados de amidas ciclicas como antagonistas da neuroquinina a
SE8404065D0 (sv) Novel biologically active compounds
ATE2265T1 (de) Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
BR9611871A (pt) Diaminopirimidinas composições farmacêuticas contendo as mesmas e seu uso como antibactericidas
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
SE8600658D0 (sv) Novel composition of matter
SE9504662D0 (sv) New compounds
ATE63563T1 (de) Synergistin-derivate, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE151770T1 (de) Cephalosporinverbindungen und deren herstellung
ATE153032T1 (de) Zyklische angiopeptin derivate, deren herstellung und pharmazeutische zusammensetzungen
DE59003446D1 (de) 13-Brom und 13, 14-Dibrom-Ergoline, ihre Herstellung und Verwendung in Arzneimitteln.
ATE150026T1 (de) Benzo(f>chinoxalindionderivative, deren herstellung und verwendung in arzneimitteln
NO178302C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte 3-tia- henholdsvis 3-oksa-alkylflavoner, samt mellomprodukter for fremgangsmåten